ArticleFrontiers in immunology2026

DOT1L promotes immune evasion in lung adenocarcinoma through H3K79me2-mediated epigenetic activation of immune checkpoints.

Xiwu Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.